Gynecomastia in NEET PG: 40-Year-Old Male with Breast Tissue — Causes, Drug Culprits & High-Yield MCQ Guide (2026)

You are probably seeing this scenario in your NEET PG practice tests: "A 40-year-old male presents with bilateral breast enlargement..." Your brain immediately goes to cancer, but wait. Gynecomastia questions appear in 8-12% of surgery and medicine papers, and they love testing the drug causes. Miss the spironolactone connection, lose 4 marks.

NEET PG examiners have a pattern. They give you a middle-aged male with breast tissue and expect you to work backwards through the hormonal chaos. The pathophysiology isnt rocket science — its an estrogen-to-testosterone ratio gone wrong. But the drug list? That is where students crash and burn.

Here is what really matters: gynecomastia affects 60-70% of adolescent males and up to 65% of men over 50. When you see it in a 40-year-old, think drugs first, then pathology. The exam wants you to nail the mechanism, spot the culprit medications, and know when to worry about malignancy.

What is Gynecomastia? The Hormonal Imbalance Behind Breast Tissue Growth

Gynecomastia is the benign enlargement of male breast tissue due to an altered estrogen-to-androgen ratio. Not pseudogynecomastia (just fat), not breast cancer — actual glandular tissue proliferation.

The core mechanism:

• Normal males: testosterone >> estrogen

• Gynecomastia: estrogen activity ↑ or testosterone activity ↓

• Result: ductal elongation and stromal proliferation

Three phases of development: 1. Proliferative phase (first 6 months): reversible tissue growth 2. Intermediate phase (6-12 months): mixed picture 3. Fibrotic phase (>12 months): irreversible fibrosis

The exam loves testing when gynecomastia becomes irreversible. Answer: after 12 months of persistent enlargement.

Physiological Gynecomastia: When Its Normal

NEET PG will test three physiological scenarios where gynecomastia is expected:

1. Neonatal Gynecomastia (First few weeks)

• Caused by maternal estrogens

• Resolves spontaneously

• No intervention needed

2. Pubertal Gynecomastia (10-14 years)

• Affects 60-70% of boys

• Peak at Tanner stage 3-4

• Usually bilateral and tender

• Resolves in 85% by age 17

3. Senescent Gynecomastia (>50 years)

• Due to declining testosterone

• Increased aromatase activity

• Often requires evaluation for underlying causes

High-yield point: Pubertal gynecomastia lasting >2 years or developing after age 14 needs investigation.

Pathological Causes: The Big 4 Categories

1. Hormonal Disorders

Primary hypogonadism (most common pathological cause):

• Klinefelter syndrome (XXY) — think tall, small testes, gynecomastia triad

• Testicular trauma, infection, or torsion

• Cryptorchidism

Secondary hypogonadism:

• Kallmann syndrome

• Pituitary adenomas

• Hyperprolactinemia

Other endocrine causes:

• Hyperthyroidism: increases SHBG, reduces free testosterone

• Adrenal disorders: CAH with 11β-hydroxylase deficiency

2. Tumors

Testicular tumors (5-10% of gynecomastia):

• Leydig cell tumors: produce estrogen

• Sertoli cell tumors: aromatase activity

• HCG-secreting tumors: seminoma, embryonal carcinoma

Non-testicular HCG-secreting tumors:

• Lung cancer (especially large cell)

• Gastric cancer

• Renal cell carcinoma

Estrogen-secreting tumors:

• Adrenal adenomas

• Liver tumors (rare)

3. Chronic Diseases

Liver cirrhosis (common in clinical practice):

• Decreased testosterone clearance

• Increased SHBG

• Enhanced aromatization

Chronic kidney disease:

• Uremia affects testosterone production

• Secondary hyperparathyroidism

Malnutrition and refeeding:

• Disrupted hormone synthesis

• Rapid weight changes

4. Drugs — The High-Yield Category

This is where NEET PG gets specific. They love drug-induced gynecomastia because the mechanism varies by medication class.

Drug-Induced Gynecomastia: The Complete List

Mechanism-based classification (this is how the exam thinks):

Anti-Androgens and Hormone Modulators

• Spironolactone (most common cause): blocks androgen receptors

• Finasteride: 5α-reductase inhibition reduces DHT

• Flutamide, bicalutamide: AR antagonists

• GnRH agonists: leuprolide, goserelin

Estrogen-Like Activity

• Digitalis: plant estrogens (phytoestrogens)

• Marijuana: contains phytoestrogens

• Anabolic steroids: aromatized to estrogen

Enzyme Inhibition

• Ketoconazole: inhibits testosterone synthesis (17,20-lyase)

• Metronidazole: similar mechanism

• Isoniazid: interferes with androgen production

Dopamine Blockers (↑ Prolactin)

• Metoclopramide

• Domperidone

• Antipsychotics: haloperidol, risperidone

H2 Blockers

• Cimetidine: anti-androgenic activity

• Ranitidine (less common)

Calcium Channel Blockers

• Nifedipine

• Verapamil

• Diltiazem

Miscellaneous

• Omeprazole: PPI with weak anti-androgenic effects

• Amiodarone: iodine content affects thyroid

• Tricyclic antidepressants

• Chemotherapy: especially alkylating agents

Exam tip: If you see spironolactone + gynecomastia, that is the answer 95% of the time. The mechanism is direct androgen receptor blockade.

Clinical Presentation: What You Need to Recognize

History Points That Matter

• Age of onset: pubertal vs adult-onset

• Unilateral vs bilateral: unilateral suggests malignancy

• Pain/tenderness: suggests recent, active growth

• Drug history: go through the list systematically

• Associated symptoms: galactorrhea (prolactin), virilization

Physical Examination

• Breast examination:

- Concentric, firm, mobile disc of tissue

- Starts beneath areola

- Distinguish from lipomastia (soft, diffuse)

• Testicular examination:

- Size, consistency, masses

- Klinefelter: small, firm testes (<15 mL)

• Secondary sexual characteristics:

- Body hair pattern

- Voice changes

- Muscle mass

Key differentials to rule out: 1. Breast cancer: hard, fixed, eccentric mass 2. Lipomastia: soft fat without glandular tissue 3. Muscle hypertrophy: pectoralis major enlargement

Diagnostic Workup: Step-by-Step Approach

First-Line Tests

1. LH, FSH, testosterone:

- Low testosterone + high LH/FSH = primary hypogonadism

- Low testosterone + low LH/FSH = secondary hypogonadism

- Normal levels = drug-induced or idiopathic

2. Prolactin: if >25 ng/mL, investigate pituitary

3. TSH: hyperthyroidism screening

4. Liver function tests: rule out cirrhosis

5. Renal function: chronic kidney disease

Second-Line Tests (If Indicated)

• Estradiol: rarely helpful unless very elevated

• HCG: if tumor suspected

• DHEAS: adrenal causes

• Karyotype: if Klinefelter suspected

Imaging

• Testicular ultrasound: if clinical suspicion of tumor

• Mammography: only if malignancy suspected (unilateral, hard mass)

• Chest X-ray: HCG-secreting lung tumors

Clinical pearl: Most gynecomastia (85%) is idiopathic or physiological. Extensive workup isnt always needed if history and exam are reassuring.

Management: When to Treat and How

Observation vs Intervention

Observe if:

• Asymptomatic

• Bilateral

• <4 cm diameter

• <12 months duration

• No underlying pathology

Treat if:

• Painful or tender

• Cosmetically bothersome

• Psychological impact

• Persistent >2 years (in adolescents)

Medical Management

For reversible cases (<12 months):

1. Tamoxifen (first choice):
- Dose: 10-20 mg daily for 6 months
- SERM — blocks estrogen receptors in breast
- Response rate: 60-80%

2. Aromatase inhibitors (second choice):
- Anastrozole 1 mg daily
- Blocks estrogen synthesis
- Less evidence than tamoxifen

3. Androgens (limited use):
- Testosterone if hypogonadal
- Risk of aromatization to estrogen

Surgical Management

Indications:

• Failed medical therapy

• Fibrotic gynecomastia (>12 months)

• Severe cosmetic deformity

• Suspected malignancy

Procedures: 1. Subcutaneous mastectomy: removal of glandular tissue 2. Liposuction: for lipomastia component 3. Combined approach: most common for grade 2-3 Surgical grading system:

• Grade 1: Small enlargement, no skin excess

• Grade 2: Moderate enlargement ± skin excess

• Grade 3: Marked enlargement with skin excess

High-Yield MCQ Patterns: What NEET PG Tests

Pattern 1: Drug Identification

"A 45-year-old male on treatment for heart failure develops bilateral breast enlargement. Which drug is most likely responsible?"

Answer approach:

• Look for heart failure = spironolactone

• Other options: digoxin (less common)

• Mechanism: AR blockade vs phytoestrogens

Pattern 2: Pathophysiology

"The mechanism of spironolactone-induced gynecomastia involves:"

a) Increased estrogen synthesis

b) Androgen receptor blockade ← Correct

c) Prolactin elevation

d) Thyroid dysfunction

Pattern 3: Timing and Reversibility

"Gynecomastia becomes irreversible after:"

a) 3 months

b) 6 months

c) 12 months ← Correct

d) 24 months

Pattern 4: Clinical Scenario

"A 16-year-old boy has bilateral tender breast enlargement for 8 months. Appropriate management:"

a) Immediate surgery

b) Observation ← Correct

c) Tamoxifen

d) Testosterone therapy

Rationale: Physiological pubertal gynecomastia resolves spontaneously in 85% by age 17.

Pattern 5: Differential Diagnosis

"Which feature distinguishes gynecomastia from breast cancer in males?"

a) Bilateral presentation

b) Concentric growth from areola ← Correct

c) Size >2 cm

d) Age >40 years

Key point: Gynecomastia is concentric and mobile; cancer is eccentric, hard, and may be fixed.

Practice Questions: Test Your Knowledge

Question 1

A 42-year-old male with chronic heart failure on multiple medications develops bilateral breast enlargement over 6 months. His medications include enalapril, metoprolol, furosemide, and spironolactone. Which is the most likely cause?

a) Enalapril
b) Metoprolol
c) Furosemide
d) Spironolactone ← Correct

Explanation: Spironolactone causes gynecomastia in 5-25% of patients through androgen receptor blockade. The other medications dont typically cause gynecomastia.

Question 2

A 17-year-old male has had bilateral breast enlargement for 18 months. It started at age 15. What is the most appropriate management?

a) Observation ← Correct
b) Tamoxifen therapy
c) Surgical excision
d) Hormone replacement

Explanation: Pubertal gynecomastia can persist up to 2 years and still resolve spontaneously. Surgery is considered only after 2 years of persistence with significant cosmetic concern.

Question 3

Which investigation is most useful in a 35-year-old male with unilateral breast enlargement?

a) Serum testosterone
b) Mammography ← Correct
c) Thyroid function
d) Liver function tests

Explanation: Unilateral breast enlargement in adults raises suspicion of malignancy and requires imaging evaluation with mammography or ultrasound.

For more practice with surgery MCQs, check out our comprehensive breast surgery questions and general surgery principles to master these high-yield topics.

Red Flags: When Gynecomastia Needs Urgent Evaluation

Immediate Referral Indicators

1. Unilateral enlargement in adults 2. Hard, fixed mass on examination 3. Rapid growth over weeks 4. Nipple discharge (especially bloody) 5. Lymphadenopathy (axillary, supraclavicular) 6. Associated testicular mass

Concerning History Features

• Recent onset in older men (>50 years)

• Family history of breast/ovarian cancer

• Previous radiation to chest

• Klinefelter syndrome (higher cancer risk)

Remember: Male breast cancer accounts for <1% of all breast cancers, but unilateral gynecomastia in adults needs imaging to rule it out.

Special Considerations for NEET PG

Klinefelter Syndrome Connection

• Karyotype: 47, XXY (most common)

• Clinical triad: tall stature, small testes, gynecomastia

• Additional features: learning difficulties, infertility

• Cancer risk: 20× higher risk of breast cancer

• Management: testosterone replacement + regular screening

Thyrotoxicosis and Gynecomastia

• Mechanism: increased SHBG reduces free testosterone

• Additional signs: weight loss, palpitations, tremor

• Investigation: suppressed TSH, elevated T3/T4

• Treatment: antithyroid drugs resolve gynecomastia

Liver Cirrhosis Pathophysiology

• Multiple mechanisms:

- Decreased testosterone metabolism

- Increased SHBG production

- Enhanced peripheral aromatization

- Alcohol-related testicular toxicity

Study these pathways in detail with our endocrinology lessons and pharmacology modules covering drug side effects.

Frequently Asked Questions

What is the most common cause of gynecomastia in a 40-year-old male?

Drug-induced gynecomastia, particularly from spironolactone, is the leading cause in middle-aged men. Other common culprits include cimetidine, ketoconazole, and calcium channel blockers.

When does gynecomastia become irreversible?

Gynecomastia becomes irreversible after 12 months of persistent enlargement due to fibrosis replacing the initial ductal proliferation. Medical therapy is most effective within the first 6 months.

How do you differentiate gynecomastia from male breast cancer?

Gynecomastia presents as bilateral, concentric, mobile breast tissue beneath the areola. Male breast cancer is typically unilateral, hard, eccentric, and may be fixed to underlying structures with possible nipple retraction.

What is the first-line medical treatment for gynecomastia?

Tamoxifen 10-20 mg daily for 6 months is the first-line medical treatment for symptomatic or bothersome gynecomastia of less than 12 months duration.

Which hormone levels should be checked in gynecomastia evaluation?

First-line hormonal tests include testosterone, LH, FSH, and prolactin. TSH should also be checked to rule out hyperthyroidism. Estradiol is rarely helpful unless markedly elevated.

Is surgery always required for gynecomastia?

No, surgery is reserved for cases that fail medical therapy, cause significant psychological distress, or persist beyond 12-24 months (especially in adolescents). Most physiological gynecomastia resolves spontaneously.

Prepare smarter with Oncourse AI — adaptive MCQs, spaced repetition, and AI explanations built for NEET PG. Download free on Android and iOS.